BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37117188)

  • 1. Pancreatic cancer is associated with medication changes prior to clinical diagnosis.
    Zhang Y; Wang QL; Yuan C; Lee AA; Babic A; Ng K; Perez K; Nowak JA; Lagergren J; Stampfer MJ; Giovannucci EL; Sander C; Rosenthal MH; Kraft P; Wolpin BM
    Nat Commun; 2023 Apr; 14(1):2437. PubMed ID: 37117188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
    Xu B; Chen Y; Peng M; Zheng JH; Zuo C
    Int J Cancer; 2023 Jan; 152(2):110-122. PubMed ID: 35765844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
    Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
    J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
    Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
    Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
    Tan PS; Garriga C; Clift A; Liao W; Patone M; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
    Gut; 2023 Mar; 72(3):512-521. PubMed ID: 35760494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.
    Parikh DA; Durbin-Johnson B; Urayama S
    J Gastrointest Cancer; 2014 Mar; 45(1):74-9. PubMed ID: 24272911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of epigenetics in pancreatic ductal adenocarcinoma.
    Pandey S; Gupta VK; Lavania SP
    Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal adenocarcinoma.
    Takeda Y; Matsumoto K; Kurumi H; Koda H; Yamashita T; Onoyama T; Kawata S; Horie Y; Isomoto H
    Dig Endosc; 2018 Nov; 30(6):771-776. PubMed ID: 29873113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.
    Xiao Y; Chen W; Xie Z; Shao Z; Xie H; Qin G; Zhao N
    BMC Cancer; 2017 Jan; 17(1):25. PubMed ID: 28056913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art and future directions of pancreatic ductal adenocarcinoma therapy.
    Neuzillet C; Tijeras-Raballand A; Bourget P; Cros J; Couvelard A; Sauvanet A; Vullierme MP; Tournigand C; Hammel P
    Pharmacol Ther; 2015 Nov; 155():80-104. PubMed ID: 26299994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.
    Igbinigie E; Guo F; Jiang SW; Kelley C; Li J
    Clin Chim Acta; 2019 Jan; 488():226-234. PubMed ID: 30452897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognostic impact of asymptomatic pancreatic cancer.
    Takikawa T; Kikuta K; Hamada S; Kume K; Miura S; Yoshida N; Tanaka Y; Matsumoto R; Ikeda M; Kataoka F; Sasaki A; Nakagawa K; Unno M; Masamune A
    Sci Rep; 2022 Mar; 12(1):4262. PubMed ID: 35277545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
    Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
    Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study of early pancreatic cancer in Japan.
    Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
    Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.